Cargando…

The Genetic Makeup of Myeloproliferative Neoplasms: Role of Germline Variants in Defining Disease Risk, Phenotypic Diversity and Outcome

Myeloproliferative neoplasms are hematologic malignancies typified by a substantial heritable component. Germline variants may affect the risk of developing a MPN, as documented by GWAS studies on large patient cohorts. In addition, once the MPN occurred, inherited host genetic factors can be respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masselli, Elena, Pozzi, Giulia, Carubbi, Cecilia, Vitale, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534117/ https://www.ncbi.nlm.nih.gov/pubmed/34685575 http://dx.doi.org/10.3390/cells10102597

Ejemplares similares

Cytokine Profiling in Myeloproliferative Neoplasms: Overview on Phenotype Correlation, Outcome Prediction, and Role of Genetic Variants
por: Masselli, Elena, et al.
Publicado: (2020)

Tracking fibrosis in myeloproliferative neoplasms by CCR2 expression on CD34(+) cells
por: Pozzi, Giulia, et al.
Publicado: (2022)

NK cells: A double edge sword against SARS-CoV-2
por: Masselli, Elena, et al.
Publicado: (2020)

Functionally Relevant Cytokine/Receptor Axes in Myelofibrosis
por: Pozzi, Giulia, et al.
Publicado: (2023)

The germline sequence variant rs2736100_C in TERT associates with myeloproliferative neoplasms
por: Oddsson, A, et al.
Publicado: (2014)

ROS in Platelet Biology: Functional Aspects and Methodological Insights
por: Masselli, Elena, et al.
Publicado: (2020)

Buffering Adaptive Immunity by Hydrogen Sulfide
por: Pozzi, Giulia, et al.
Publicado: (2022)

Defining the Thrombotic Risk in Patients with Myeloproliferative Neoplasms
por: Vianello, Fabrizio, et al.
Publicado: (2011)

Germline ERBB2/HER2 Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms
por: Braunstein, Evan M., et al.
Publicado: (2021)

Mutations, inflammation and phenotype of myeloproliferative neoplasms
por: Hermouet, Sylvie
Publicado: (2023)

Combination of Platelet expression of PKCepsilon and cardiac troponin-I for early diagnosis of chest pain patients in the emergency department
por: Carubbi, Cecilia, et al.
Publicado: (2019)

Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms
por: Goldin, Lynn R, et al.
Publicado: (2009)

Common germline variation at the TERT locus contributes to familial clustering of myeloproliferative neoplasms
por: Jäger, Roland, et al.
Publicado: (2014)

Myeloproliferative neoplasms
por: Cross, Nick
Publicado: (2019)

Myeloproliferative neoplasms
por: Kiladjian, Jean-Jacques
Publicado: (2018)

Interplay between Protein Kinase C Epsilon and Reactive Oxygen Species during Myogenic Differentiation
por: Pozzi, Giulia, et al.
Publicado: (2023)

P1050: NEXT GENERATION SEQUECING CONTRIBUTES TO DEFINE PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASM CLINICAL PHENOTYPE
por: Leone, Aldo, et al.
Publicado: (2023)

Stage makeup /
por: Buchman, Herman
Publicado: (1989)

Discovery of a signaling feedback circuit that defines interferon responses in myeloproliferative neoplasms
por: Saleiro, Diana, et al.
Publicado: (2022)

Hydrogen Sulfide Inhibits TMPRSS2 in Human Airway Epithelial Cells: Implications for SARS-CoV-2 Infection
por: Pozzi, Giulia, et al.
Publicado: (2021)

Evolution led humans to bipedalism, but we live in a sedentary society: Will “Sunday running” protect us from NCDs at no cost?
por: Presta, Valentina, et al.
Publicado: (2023)

The molecular and phenotypic makeup of fetal human skin T lymphocytes
por: Reitermaier, René, et al.
Publicado: (2021)

Epigenetics in Myeloproliferative Neoplasms
por: McPherson, Suzanne, et al.
Publicado: (2017)

Aetiology of Myeloproliferative Neoplasms
por: McMullin, Mary Frances, et al.
Publicado: (2020)

The microenvironment in myeloproliferative neoplasm
por: Méndez-Ferrer, Simón, et al.
Publicado: (2018)

Spleen in myeloproliferative neoplasms
por: Barosi, Giovanni
Publicado: (2018)

Epigenetics in myeloproliferative neoplasms
por: Greenfield, Graeme, et al.
Publicado: (2023)

Genetic–pathologic characterization of myeloproliferative neoplasms
por: Kim, Yonggoo, et al.
Publicado: (2016)

Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
por: Palomo, Laura, et al.
Publicado: (2021)

The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity
por: Masselli, Elena, et al.
Publicado: (2018)

Faces with Light Makeup Are Better Recognized than Faces with Heavy Makeup
por: Tagai, Keiko, et al.
Publicado: (2016)

Impact of the rs1024611 Polymorphism of CCL2 on the Pathophysiology and Outcome of Primary Myelofibrosis
por: Masselli, Elena, et al.
Publicado: (2021)

Relationship between disease biology and clinical phenotype in myeloproliferative neoplasms
por: Nangalia, Jyoti
Publicado: (2019)

Effects of CALR-Mutant Type and Burden on the Phenotype of Myeloproliferative Neoplasms
por: Kim, Hyun-Young, et al.
Publicado: (2022)

Myelofibrotic and leukemic transformation in 2016 WHO-defined Philadelphia-negative myeloproliferative neoplasm
por: Song, Ik-Chan, et al.
Publicado: (2022)

Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
por: Marin Oyarzún, Cecilia P., et al.
Publicado: (2019)

Genetic basis and molecular profiling in myeloproliferative neoplasms
por: Luque Paz, Damien, et al.
Publicado: (2023)

CHST15 gene germline mutation is associated with the development of familial myeloproliferative neoplasms and higher transformation risk
por: Chen, Yi, et al.
Publicado: (2022)

Deactylase inhibition in myeloproliferative neoplasms
por: Mithraprabhu, Sridurga, et al.
Publicado: (2010)

Guidelines for the management of myeloproliferative neoplasms
por: Choi, Chul Won, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k081o0f43qr9p6leepoqap5a85